Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. eP129

   Prokaryotic chimera protein consisting of multiple M2e of influenza A virus and Leishmania major HSP70 induced specific immune responses in mice

   Fatemeh Fotouhi, Tehran, Iran, Islamic Republic of

   Fotouhi, F.(1)*; Taheri, N.(2); Soleimanjahi, H.(3); Farahmand, B.(4); Kheiri, M.T.(4); Torabi, A.(4);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

2. eP130

   Chimeric influenza virosome

   Masoumeh Tavassoti Kheiri, Tehran, Iran, Islamic Republic of

   Tavassoti Kheiri, M.(1)*; Abdoli, A.(1); Soleimanjahi, H.(2); Jamali, A.(1);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

3. eP131

   The cost-effectiveness of vaccination against seasonal influenza in England

   Marc Baguelin, London, United Kingdom

   Baguelin, M.(1)*; Camacho, A.(2); Flasche, S.(2); Edmunds, J.W.(2);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

4. eP132

   A phase II study of the safety and immunogenicity of different formulations of a candidate Clostridium difficile toxoid vaccine: dose and formulation selection for phase III

   Guy de Bruyn, Swiftwater, United States

   de Bruyn, G.(1)*; Foglia, G.(1); Saleh, J.(2); Workman, D.(3); Pollak, R.(4); Gesser, R.(1);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

5. eP133

   A phase II study of the safety and immunogenicity of different vaccination schedules of a candidate Clostridium difficile toxoid vaccine: vaccination schedule selection for phase II

   Guy de Bruyn, Swiftwater, United States

   de Bruyn, G.(1)*; Foglia, G.(1); Saleh, J.(2); Workman, D.(3); Pollak, R.(4); Gesser, R.(1);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

6. eP134

   Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy adults: results of a randomised, placebo-controlled first-in-human phase 1/2 study

   Robert Frenck, Cincinnati, OH, United States

   Frenck, R.(1)*; Buddy Creech, C.(2); Sheldon, E.(3); Seiden, D.J.(4); Kankam, M.(5); Baber, J.(6); Zito, E.(7); Hubler, R.(7); Eiden, J.(8); Severs, J.M.(8); Sebastian, S.(8); Nanra, J.(8); Jansen, K.U.(8); Anderson, A.S.(8); Girgenti, D.(8);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

7. eP135

   Development and evaluation of Staphylococcus epidermidis DNA, mRNA and protein vaccines

   Lin Yan, Seattle, United States

   Yan, L.(1)*; Bryers, J.(1);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

8. eP136

   Analysis of the proteome of a modified vaccinia virus Ankara-based vaccine provides insight into the effects of transgenic modification on virus physiology

   Arinze Stanley Okoli, Tromsoe, Norway

   Okoli, A.S.(1)*; Okeke, M.I.(1); Tummler, C.(2); Moens, U.(2); Nilssen, Ø.(2); Tryland, M.(2); Ansgar-Bruun, J.(2); Bøhn, T.(2); Traavik, T.(2);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

9. eP137

   T-helper cell cytokine pattern induced by synthetic manno-and gluco-oligosaccharide conjugates

   Ru*ena Pili*iová, Bratislava, Slovakia

   Paulovicova, E.(1); Pilisiova, R.(1)*; Paulovicova, L.(1); Yashunsky, D.V.(2); Karelin, A.A.(2); Tsvetkov, Y.E.(2); Nifantiev, N.E.(2);

   10 May 2014

   Session: Vaccine development

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   ePoster presentation

   Immunology & Vaccinology

10. eP138

    Immunisation with enolase of Trypanosoma cruzi confers protective immunity against acute phase of Chagas disease in mice

    Alejandro Carabarin-Lima, Puebla, Mexico

    Carabarin-Lima, A.(1); Cortés-Cortés, G.(2)*; González-Vázquez, M.C.(3); Rodríguez-Morales, O.(1); Reyes, P.A.(1); Arce-Fonseca, M.(1); Rosales-Encina, J.L.(4);

    10 May 2014

    Session: Vaccine development

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    ePoster presentation

    Immunology & Vaccinology